Gene · 9846
Papers1,533
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,533
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer. | Cancers (Basel) | 2021 | 34885103 | PubTator, text mining | PubMed |
| Gene Expression in Barrett's Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma. | Cancers (Basel) | 2021 | 34885081 | PubTator, text mining | PubMed |
| Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report. | Ann N Y Acad Sci | 2021 | 34850398 | PubTator, text mining | PubMed |
| Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma. | Biomedicines | 2021 | 34829830 | PubTator, text mining | PubMed |
| STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer. | J Hematol Oncol | 2021 | 34809691 | PubTator, text mining | PubMed |
| Integrative Bioinformatics approaches to therapeutic gene target selection in various cancers for Nitroglycerin. | Sci Rep | 2021 | 34764329 | PubTator, text mining | PubMed |
| Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation. | Cell Biosci | 2021 | 34736535 | PubTator, text mining | PubMed |
| Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance. | PLoS Comput Biol | 2021 | 34735429 | PubTator, text mining | PubMed |
| Association of Single-Nucleotide Polymorphisms of Gab1 Gene with Susceptibility to Meningioma in a Northern Chinese Han Population. | Med Sci Monit | 2021 | 34732686 | PubTator, text mining | PubMed |
| Targeting Oncogenic Src Homology 2 Domain-Containing Phosphatase 2 (SHP2) by Inhibiting Its Protein-Protein Interactions. | J Med Chem | 2021 | 34714648 | PubTator, text mining | PubMed |
| Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer's Disease. | Front Immunol | 2021 | 34712240 | PubTator, text mining | PubMed |
| Multiomics landscape of the autosomal dominant osteopetrosis type II disease-specific induced pluripotent stem cells. | Hereditas | 2021 | 34702373 | PubTator, text mining | PubMed |
| ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer. | Cells | 2021 | 34685488 | PubTator, text mining | PubMed |
| Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. | Cell Rep Methods | 2021 | 34671754 | PubTator, text mining | PubMed |
| LncRNA SLCO4A1-AS1 Accelerates Growth and Metastasis of Gastric Cancer via Regulation of the miR-149/XIAP Axis. | Front Oncol | 2021 | 34650909 | PubTator, text mining | PubMed |
| Disturbance of phylogenetic layer-specific adaptation of human brain gene expression in Alzheimer's disease. | Sci Rep | 2021 | 34642398 | PubTator, text mining | PubMed |
| Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax Sensitivity. | Cancers (Basel) | 2021 | 34638381 | PubTator, text mining | PubMed |
| Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia-From Molecular Mechanisms to Clinical Relevance. | Cancers (Basel) | 2021 | 34638304 | PubTator, text mining | PubMed |
| Circular RNA ERBB2 Contributes to Proliferation and Migration of Airway Smooth Muscle Cells via miR-98-5p/IGF1R Signaling in Asthma. | J Asthma Allergy | 2021 | 34616159 | PubTator, text mining | PubMed |
| Determining folding and binding properties of the C-terminal SH2 domain of SHP2. | Protein Sci | 2021 | 34605082 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9846/papers?page=17